Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)
Clinical trial NCT01380938 · COMPLETED
Trial details
- NCT number
- NCT01380938
- Sponsor
- Casa Sollievo della Sofferenza IRCCS
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2019-11-30
- Enrollment
- 1150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.